Related Experiment Video
Updated: Aug 10, 2026

Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4
Published on: December 31, 2013
Different vanilloid agonists cause different patterns of calcium response in CHO cells heterologously expressing rat
Attila Tóth1, Yun Wang, Noémi Kedei
1Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, National Institutes of Health, Bldg. 37, Room 4048, 37 Convent Dr., MSC 4255, Bethesda, MD 20892-4255, United States.
Abstract:
The vanilloid receptor subtype 1 (TRPV1 or VR1) is expressed in nociceptive primary afferents of the C-fiber 'pain' pathway and has attracted considerable attention as a therapeutic target. Here, using rat TRPV1 heterologously expressed in Chinese hamster ovary cells, we show that different agonists show different patterns of modulation of the intracellular Ca2+ concentration, monitored in individual cells by fura-2 Ca2+ imaging. We identified 5 parameters (potency, maximal response, latency of response, variability of latency of response among individual cells, and desensitization) which behaved differently for different compounds. The potencies of the compounds examined ranged from EC50 values of 80 pM to 9 microM. Peak levels of induced [Ca2+]i were observed either higher (RTX) or lower (anandamide) than for capsaicin. Significant latencies of response were observed for some (e.g. RTX) but not other derivatives, with great variation among individual cells in this latency. Marked desensitization after stimulation was detected in some cases (e.g. anandamide, capsaicin); for others, no desensitization was observed. We conclude that structurally diverse vanilloid agonists induce marked diversity in the patterns of Ca2+ response. This diversity of response may provide opportunities for pharmacological exploitation.
Insights
Diverse vanilloid agonists targeting the TRPV1 receptor show varied effects on intracellular calcium levels. This calcium response diversity offers potential for developing new pain therapeutics.
Area of Science:
- Pharmacology
- Neuroscience
- Cell Biology
Background:
- The vanilloid receptor subtype 1 (TRPV1), expressed in C-fiber pain pathways, is a key therapeutic target.
- Understanding TRPV1 agonist interactions is crucial for pain management strategies.
Purpose of the Study:
- To investigate the diverse intracellular Ca2+ response patterns induced by various vanilloid agonists on rat TRPV1.
- To identify key parameters characterizing these diverse responses for potential drug development.
Main Methods:
- Heterologous expression of rat TRPV1 in Chinese hamster ovary (CHO) cells.
- Fura-2 calcium imaging to monitor intracellular Ca2+ concentration in individual cells.
- Analysis of five response parameters: potency, maximal response, latency, latency variability, and desensitization.
Main Results:
- Agonists exhibited a wide range of potencies (EC50 from 80 pM to 9 µM).
- Peak intracellular Ca2+ levels varied significantly between compounds (e.g., RTX vs. anandamide).
- Response latencies and desensitization patterns differed markedly among agonists, indicating compound-specific effects.
Conclusions:
- Structurally diverse vanilloid agonists elicit distinct intracellular Ca2+ response profiles.
- The observed diversity in TRPV1-mediated Ca2+ signaling presents opportunities for targeted pharmacological interventions.
Related Concept Videos
Mechanically-gated Ion Channels
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Antihypertensive Drugs: Action of Calcium Channel Blockers

